| Antonella Lanni, | |
|
5514 Medwick Garth N, Catonsville, MD 21228-1941 | |
| (443) 762-4563 | |
| Not Available |
| Full Name | Antonella Lanni |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 5514 Medwick Garth N, Catonsville, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427286533 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 04697 (Maryland) | Primary |
| 225X00000X | Occupational Therapist | 9586 (Massachusetts) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Antonella Lanni, 5514 Medwick Garth N, Catonsville, MD 21228-1941 Ph: () - | Antonella Lanni, 5514 Medwick Garth N, Catonsville, MD 21228-1941 Ph: (443) 762-4563 |
News Archive
Aastrom Biosciences, Inc., the leading developer of autologous cellular therapies for the treatment of severe cardiovascular diseases, today reported financial results for its third fiscal quarter ended March 31, 2010, and also announced progress in its late-stage clinical development programs and corporate operations.
Idera Pharmaceuticals, Inc. announced today that positive interim data from a Phase 1 clinical trial of IMO-2125, a Toll-like Receptor 9 (TLR9) agonist, in null responder patients with chronic hepatitis C virus (HCV) infection were presented at the 45th Annual Meeting of the European Association for the Study of the Liver (EASL).
Blood that has been stored for 2 weeks or more before being used in transfusions for critically ill patients does not appear to cause adverse effects, report US researchers.
An international team of scientists-including researchers at GENYO, the Centre for Genomics and Oncological Research (Pfizer-University of Granada- Andalusian Regional Government)-has described a molecular mechanism that facilitates the defence of the human genome against "bombarding" by mobile DNA sequences.
Mesenchymal stem cells (MSCs), are a newly emerging cellular therapy being tested in approximately 250 clinical trials worldwide to help repair damaged tissues, such as injured heart muscle following a heart attack. The problem is that when culture-expanded MSCs are injected into the circulation, they have trouble gaining access to the inflamed tissues-exactly where their help is needed.
› Verified 3 days ago
Mrs. Denise Lynn Furnary, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 613 Olesmont Rd, Catonsville, MD 21228 Phone: 410-294-2109 | |
Mrs. Radiatou Boucar, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1525 N Rolling Rd, Catonsville, MD 21228 Phone: 410-402-1200 | |
Stephanie Riley, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 701 Edmondson Ave, Catonsville, MD 21228 Phone: 410-747-7425 | |
Julie Jung Hebert, OTR,L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1525 N Rolling Rd, Catonsville, MD 21228 Phone: 469-556-3633 | |
Chloe Warnick, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 715 Maiden Choice Ln, Catonsville, MD 21228 Phone: 410-737-8859 | |
Tayler Hayes, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 16 Fusting Ave, Catonsville, MD 21228 Phone: 410-747-1800 | |
Kathleen Roseboom, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 502 Hilton Ave, Catonsville, MD 21228 Phone: 410-375-4226 |